Literature DB >> 30612897

New Binding Sites, New Opportunities for GPCR Drug Discovery.

H C Stephen Chan1, Yi Li2, Thamani Dahoun3, Horst Vogel3, Shuguang Yuan4.   

Abstract

Many central biological events rely on protein-ligand interactions. The identification and characterization of protein-binding sites for ligands are crucial for the understanding of functions of both endogenous ligands and synthetic drug molecules. G protein-coupled receptors (GPCRs) typically detect extracellular signal molecules on the cell surface and transfer these chemical signals across the membrane, inducing downstream cellular responses via G proteins or β-arrestin. GPCRs mediate many central physiological processes, making them important targets for modern drug discovery. Here, we focus on the most recent breakthroughs in finding new binding sites and binding modes of GPCRs and their potentials for the development of new medicines.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Keywords:  GPCR; binding sites; drug discovery; drug targets; protein–ligand interactions

Mesh:

Substances:

Year:  2019        PMID: 30612897     DOI: 10.1016/j.tibs.2018.11.011

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  35 in total

Review 1.  Extramembranous Regions in G Protein-Coupled Receptors: Cinderella in Receptor Biology?

Authors:  Sreetama Pal; Amitabha Chattopadhyay
Journal:  J Membr Biol       Date:  2019-08-30       Impact factor: 1.843

2.  Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1.

Authors:  Jamie C Fox; Monica A Thomas; Acacia F Dishman; Olav Larsen; Takashi Nakayama; Osamu Yoshie; Mette Marie Rosenkilde; Brian F Volkman
Journal:  Sci Signal       Date:  2019-09-03       Impact factor: 8.192

3.  Role of Actin Cytoskeleton in Dynamics and Function of the Serotonin1A Receptor.

Authors:  Sandeep Shrivastava; Parijat Sarkar; Pascal Preira; Laurence Salomé; Amitabha Chattopadhyay
Journal:  Biophys J       Date:  2019-09-05       Impact factor: 4.033

4.  Druggability assessment of mammalian Per-Arnt-Sim [PAS] domains using computational approaches.

Authors:  João V de Souza; Sylvia Reznikov; Ruidi Zhu; Agnieszka K Bronowska
Journal:  Medchemcomm       Date:  2019-05-13       Impact factor: 3.597

Review 5.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

6.  Calcium as a biased cofactor.

Authors:  Madhu Chaturvedi; Arun K Shukla
Journal:  Science       Date:  2020-04-24       Impact factor: 47.728

Review 7.  Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.

Authors:  Mootaz M Salman; Zaid Al-Obaidi; Philip Kitchen; Andrea Loreto; Roslyn M Bill; Richard Wade-Martins
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

8.  Cholesterol in GPCR Structures: Prevalence and Relevance.

Authors:  Parijat Sarkar; Amitabha Chattopadhyay
Journal:  J Membr Biol       Date:  2021-08-07       Impact factor: 1.843

Review 9.  Non-peptide agonists and positive allosteric modulators of glucagon-like peptide-1 receptors: Alternative approaches for treatment of Type 2 diabetes.

Authors:  Faisal Malik; Zhijun Li
Journal:  Br J Pharmacol       Date:  2021-04-19       Impact factor: 8.739

Review 10.  Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases.

Authors:  Salomé Gonçalves-Monteiro; Rita Ribeiro-Oliveira; Maria Sofia Vieira-Rocha; Martin Vojtek; Joana B Sousa; Carmen Diniz
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.